Perseus Proteomics Inc.
Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.
4882 | T
Overview
Corporate Details
- ISIN(s):
- JP3836800007
- LEI:
- Country:
- Japan
- Address:
- 目黒区駒場四丁目７番６号
- Website:
- https://www.ppmx.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Perseus Proteomics Inc. is a drug discovery biotechnology company founded in 2001 as a venture from the University of Tokyo. The company focuses on creating novel antibody-based therapeutics to treat cancer and other diseases, utilizing its proprietary and unique antibody technologies. Its business operations are structured around three core segments: Drug Discovery, which develops its pipeline of potential antibody drugs; Antibody Research Support Services for partner institutions; and the direct sale of antibody products and diagnostic reagents, such as ELISA kits. The company's mission is to contribute to global healthcare by developing innovative treatments for people suffering from diseases worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-14 07:32 |
Registration Form
確認書
|
Japanese | 8.2 KB | ||
| 2025-11-14 07:32 |
Interim Report
半期報告書－第26期(2025/04/01－2026/03/31)
|
Japanese | 160.8 KB | ||
| 2025-06-27 09:28 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 25.9 KB | ||
| 2025-06-27 08:34 |
Registration Form
確認書
|
Japanese | 8.2 KB | ||
| 2025-06-27 08:33 |
Registration Form
訂正有価証券報告書－第24期(2023/04/01－2024/03/31)
|
Japanese | 1.5 MB | ||
| 2025-06-27 08:33 |
Registration Form
確認書
|
Japanese | 8.2 KB | ||
| 2025-06-27 08:32 |
Annual Report
訂正有価証券報告書－第23期(2022/04/01－2023/03/31)
|
Japanese | 1.5 MB | ||
| 2025-06-27 08:32 |
Governance Information
内部統制報告書－第25期(2024/04/01－2025/03/31)
|
Japanese | 22.4 KB | ||
| 2025-06-27 08:31 |
Registration Form
確認書
|
Japanese | 8.1 KB | ||
| 2025-06-27 08:31 |
Annual Report
有価証券報告書－第25期(2024/04/01－2025/03/31)
|
Japanese | 2.6 MB | ||
| 2025-05-21 08:31 |
Regulatory News Service
臨時報告書
|
Japanese | 20.2 KB | ||
| 2024-11-14 07:34 |
Report Publication Announcement
確認書
|
Japanese | 8.1 KB | ||
| 2024-11-14 07:34 |
Interim Report
半期報告書－第25期(2024/04/01－2025/03/31)
|
Japanese | 163.4 KB | ||
| 2024-06-20 07:40 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 23.6 KB | ||
| 2024-06-20 07:34 |
Governance Information
内部統制報告書－第24期(2023/04/01－2024/03/31)
|
Japanese | 21.2 KB |
Automate Your Workflow. Get a real-time feed of all Perseus Proteomics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Perseus Proteomics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Perseus Proteomics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
